The Global Interleukin6 – il6 – Inhibitors Market is expected to reach US$ 93.3 billion by 2033, at a CAGR of 10.9%, according to a report by Future Market Insights. Interleukin-6 (IL-6) Inhibitors, a proinflammatory cytokine, is produced by different types of cell which includes monocytes, fibroblasts and lymphocytes. The demand for immune-based therapies is …